Cargando…
The Future of Clinical Phage Therapy in the United Kingdom
Bacteriophage (phage) therapy is a promising alternative antimicrobial strategy with the potential to transform the way bacterial infections are treated. In the United Kingdom, phages are classed as a biological medicine. Although no phages are licensed for UK use, they may be used as unlicensed med...
Autores principales: | Jones, Joshua D., Trippett, Clare, Suleman, Mehrunisha, Clokie, Martha R. J., Clark, Jason R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053292/ https://www.ncbi.nlm.nih.gov/pubmed/36992430 http://dx.doi.org/10.3390/v15030721 |
Ejemplares similares
-
Managing Patient and Clinician Expectations of Phage Therapy in the United Kingdom
por: Jones, Joshua D., et al.
Publicado: (2023) -
The practical, ethical and legal reasons why patients should not be
transferred between NHS trusts for phage therapy
por: Jones, Joshua D, et al.
Publicado: (2022) -
Genomic Characterization of Jumbo Salmonella Phages That Effectively Target United Kingdom Pig-Associated Salmonella Serotypes
por: Thanki, Anisha M., et al.
Publicado: (2019) -
Phage therapy: Awareness and demand among clinicians in the United Kingdom
por: Simpson, Emily A., et al.
Publicado: (2023) -
Preclinical data and safety assessment of phage therapy in humans
por: Nale, Janet Y, et al.
Publicado: (2021)